Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Purple Biotech Ltd ADR (PPBT)

Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Purple Biotech Ltd ADR 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 ISR

www.purple-biotech.com P: 972-3933-3121 F: 972-350-9719

Description:

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

Key Statistics

Overview:

Market Capitalization, $K 13,358
Enterprise Value, $K -1,132
Shares Outstanding, K 25,238
Annual Sales, $ 0 K
Annual Net Income, $ -19,880 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,830 K
EBIT, $ -22,280 K
EBITDA, $ -22,080 K
60-Month Beta 1.01
% of Insider Shareholders 2.98%
% of Institutional Shareholders 9.64%
Float, K 24,486
% Float 97.02%
Short Volume Ratio 0.35

Growth:

1-Year Return -71.31%
3-Year Return -86.83%
5-Year Return -94.86%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 70.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 03/05/24
Latest Earnings Date 05/21/24
Earnings Per Share ttm -1.05
EPS Growth vs. Prev Qtr -39.13%
EPS Growth vs. Prev Year -6.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 08/21/20

PPBT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.40%
Return-on-Assets % -49.02%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.38
Book Value/Share 1.36
Interest Coverage -8.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar